Moneycontrol

Budget 2023Budget 2023

PARTNERS

  • Tata AIA Life Insurance
  • Hafele
  • Motilal Oswal
  • SMC Global Securities Limited
  • SBI Life
Upcoming Event : LeapToUnicorn - mentoring, networking and fundraising for startups. Register now
Budget 2023
Budget 2023

Alembic Pharma gets USFDA nod for generic drug

The approval by the US Food & Drug Administration (USFDA) for the abbreviated new drug application (ANDA) of diclofenac sodium topical solution is for strength of 2 per cent, the company said in a statement.

December 01, 2022 / 02:10 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Alembic Pharmaceuticals on Thursday said it has received final approval from the US health regulator for its generic version of diclofenac sodium topical solution indicated to treat pain of osteoarthritis of the knee.

The approval by the US Food & Drug Administration (USFDA) for the abbreviated new drug application (ANDA) of diclofenac sodium topical solution is for strength of 2 per cent, the company said in a statement.

"The ANDA was filed by Aleor Dermaceuticals (Aleor), which was amalgamated with Alembic," it added. Aleor had previously received a tentative approval for this ANDA.

The approved ANDA is therapeutically equivalent to the reference listed drug product Pennsaid topical solution, 2 per cent of Horizon Therapeutics Ireland DAC (Horizon), Alembic said.